UCI MIND Symposium: Advancing Frontiers in Alzheimer's Research and Therapy

After nearly 19 years, the U.S. FDA has approved a new drug for Alzheimer’s disease for the first time, sparking widespread global discussion. This development prompts pressing questions: What are the latest advances in Alzheimer’s research and treatment? What challenges remain in the prevention and management of Alzheimer’s disease? And how should we respond to these issues?

The University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI Mind), an Alzheimer’s disease research center designated by the U.S. National Institutes of Health (NIH), will host an online event via Zoom on June 26, 2021, from 9:30 to 10:30 a.m. Dr. Joshua Grill, Director of UCI Mind, will share insights from his research. You are cordially invited to attend!

Scan the QR code below to register. The meeting link will be sent via message upon successful registration.